US Patent Issued to KING FAISAL UNIVERSITY on April 8 for "Substituted pyrazino[1',2':1,5pyrazolo[4,3-c[1,6naphthyridines as CK2 inhibitors" (Saudi Arabia Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,827, issued on April 8, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"Substituted pyrazino[1',2':1,5pyrazolo[4,3-c[1,6naphthyridines as CK2 inhibitors" was invented by Christophe Tratrat (Al-Ahsa, Saudi Arabia) and Michelyne Haroun (Al-Ahsa, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel pyrazino[1',2':1,5]pyrazolo[4,3-c][1,6]naphthyridine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrazino[1',2':1,5]pyrazolo[4,3-c][1,6]naphthyridine compounds, identified as CK2 inhibitors, are useful ...